Literature DB >> 29080678

Genome-Wide MicroRNA Analysis Implicates miR-30b/d in the Etiology of Alopecia Areata.

Aylar Tafazzoli1, Andreas J Forstner2, David Broadley3, Andrea Hofmann1, Silke Redler4, Lynn Petukhova5, Kathrin A Giehl6, Roland Kruse7, Bettina Blaumeiser8, Markus Böhm9, Marta Bertolini9, Alfredo Rossi10, Natalie Garcia Bartels11, Gerhard Lutz12, Hans Wolff6, Ulrike Blume-Peytavi11, Hermona Soreq13, Angela M Christiano14, Natalia V Botchkareva3, Markus M Nöthen1, Regina C Betz15.   

Abstract

Alopecia areata (AA) is one of the most common forms of human hair loss. Although genetic studies have implicated autoimmune processes in AA etiology, understanding of the etiopathogenesis is incomplete. Recent research has implicated microRNAs, a class of small noncoding RNAs, in diverse autoimmune diseases. To our knowledge, no study has investigated the role of microRNAs in AA. In this study, gene-based analyses were performed for microRNAs using data of the largest genome-wide association meta-analysis of AA to date. Nominally, significant P-values were obtained for 78 of the 617 investigated microRNAs. After correction for multiple testing, three of the 78 microRNAs remained significant. Of these, miR-30b/d was the most significant microRNA for the follow-up analyses, which also showed lower expression in the hair follicle of AA patients. Target gene analyses for the three microRNAs showed 42 significantly associated target genes. These included IL2RA, TNXB, and ERBB3, which had been identified as susceptibility loci in previous genome-wide association studies. Using luciferase assay, site-specific miR-30b regulation of the AA risk genes IL2RA, STX17, and TNXB was validated. This study implicates microRNAs in the pathogenesis of AA. This finding may facilitate the development of future treatment strategies.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29080678     DOI: 10.1016/j.jid.2017.09.046

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

Review 1.  Current insight into the functions of microRNAs in common human hair loss disorders: a mini review.

Authors:  Iván Licona-Vázquez; Francisco I Serrano-Cano; Natalia Frías-Reid; Carolina Pacheco-Dorantes; Sujay Paul; Surajit Pathak; Samik Chakraborty; Aashish Srivastava
Journal:  Hum Cell       Date:  2021-04-27       Impact factor: 4.174

2.  The Immunogenetics of Alopecia areata.

Authors:  Fateme Rajabi; Fahimeh Abdollahimajd; Navid Jabalameli; Mansour Nassiri Kashani; Alireza Firooz
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Authors:  Cheng Zhou; Xiangqian Li; Chen Wang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-17       Impact factor: 8.667

4.  Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis.

Authors:  Shymaa Ahmed Maher; Nader Ali Ismail; Eman A Toraih; Alaa H Habib; Nawal S Gouda; Amal H A Gomaa; Manal S Fawzy; Ghada M Helal
Journal:  Biomolecules       Date:  2022-04-19

5.  Chi-miR-370-3p regulates hair follicle morphogenesis of Inner Mongolian cashmere goats.

Authors:  Erhan Hai; Wenjing Han; Zhihong Wu; Rong Ma; Fangzheng Shang; Min Wang; Lili Liang; Youjun Rong; Jianfeng Pan; Zhiying Wang; Ruijun Wang; Rui Su; Yanhong Zhao; Zhihong Liu; Zhixin Wang; Jinquan Li; Yanjun Zhang
Journal:  G3 (Bethesda)       Date:  2021-05-07       Impact factor: 3.154

Review 6.  Emerging Topical and Systemic JAK Inhibitors in Dermatology.

Authors:  Farzan Solimani; Katharina Meier; Kamran Ghoreschi
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

Review 7.  The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases.

Authors:  Ken-Ichi Matsumoto; Hiroki Aoki
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.